31 min listen
Delirium Biomarkers
ratings:
Length:
29 minutes
Released:
Dec 5, 2022
Format:
Podcast episode
Description
Drs. Tina McKay and Zhongcong Xie discuss delirium biomarkers with Dr. Adam Striker. Learn about the latest research, the practical implications for patient safety, the connection between delirium biomarkers and Alzheimer’s disease, and more. Recorded November 2022.
This podcast episode was developed in collaboration with the Committee on Geriatric Anesthesia and funded by ASA’s Industry Supporters. Thank you to our Industry supporters for their year-round support of ASA: Baudax Bio, Edwards Lifesciences, Fresenius Kabi, GE Healthcare, Heron Therapeutics, Masimo, Medtronic, and Merck.
This podcast episode was developed in collaboration with the Committee on Geriatric Anesthesia and funded by ASA’s Industry Supporters. Thank you to our Industry supporters for their year-round support of ASA: Baudax Bio, Edwards Lifesciences, Fresenius Kabi, GE Healthcare, Heron Therapeutics, Masimo, Medtronic, and Merck.
Released:
Dec 5, 2022
Format:
Podcast episode
Titles in the series (96)
Diagnostic POCUS Certificate Program: Dr. Adam Striker discusses diagnostic Point-of-Care Ultrasound (POCUS) and ASA’s new certificate program with Dr. Yuriy Bronshteyn, editor and chief of ASA Editorial Board on Point-of-Care Ultrasound. Find out how you can benefit from participating i... by Central Line by American Society of Anesthesiologists - a podcast series for the anesthesia community